FeesSafety
Pluang+

Ethereum supply grows as new ETH issuance outpaces fee burn, pressuring price near $2,234.

Protocol Fundamentals
08 Nov 2026, 21:15 WIB
CryptoTicker
View Source
Neutral
Ethereum supply grows as new ETH issuance outpaces fee burn, pressuring price near $2,234.

Between Saturday and Sunday, nearly 3,000 new ether were created while only 10 ETH were burned due to low network fees, causing Ethereum's supply to grow by about 0.86% annually. This supply increase adds selling pressure at a time when buyer demand is weak, keeping the price stable near $2,234 but limiting upside potential. For supply to shrink again, Ethereum's base fee would need to rise significantly, which depends on higher network activity. Staking rewards help offset dilution for holders, but recent outflows from Ether funds highlight market challenges ahead.

Ethereum supply dynamics are the subject, with Pluang market data as of Nov 09, 2026 02:21 WIB. For readers following major cryptocurrencies, here is Pluang's market snapshot: out of 50 major cryptocurrencies, 8 rose and 41 fell today. Notable movers include ENJ at Rp410 with a 1-day change of -3.27%, VET at Rp93 with -3.11%, and NEO at Rp32.947 with -3.11%.

More News

NVIDIA Board launches probe into CEO Jensen Huang over foreign intelligence concerns.

NVIDIA Board launches probe into CEO Jensen Huang over foreign intelligence concerns.

NVIDIA's Board of Directors has started an independent investigation after reports that CEO Jensen Huang was targeted by a foreign intelligence operation. The inquiry, led by independent directors and external counsel, aims to ensure no national secu...

Market News
Neutral
39 minutes ago
CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics reports positive Phase 1 results for zugo-cel in treating refractory autoimmune diseases.

CRISPR Therapeutics announced encouraging Phase 1 trial results for zugo-cel, their gene-edited CAR-T cell therapy targeting refractory autoimmune diseases like systemic sclerosis, lupus, and idiopathic inflammatory myopathy. Among 21 patients treate...

Market News
Bullish
5 hours ago
Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Velinotamig shows strong safety and efficacy in treating refractory systemic lupus erythematosus, with notable kidney improvements.

Cullinan Therapeutics announced promising Phase 1b/2a trial results for velinotamig, a BCMAxCD3 T cell engager, in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE). Among nine evaluable patients, eight showed significant...

Market News
Bullish
5 hours ago
3 stocks with recurring revenue face challenges but offer long-term growth potential.

3 stocks with recurring revenue face challenges but offer long-term growth potential.

Three companies—Otis Worldwide, Rollins, and Republic Services—offer recurring revenue through essential services like elevator maintenance, pest control, and waste management. Despite their steady cash flows and customer loyalty, Otis and Rollins fa...

Market News
Neutral
5 hours ago
Four large crypto transfers worth $637.6M occurred in three hours, mostly Bitcoin and Tether to Bitfinex.

Four large crypto transfers worth $637.6M occurred in three hours, mostly Bitcoin and Tether to Bitfinex.

Within a three-hour window ending Nov. 6 at 4:01 p.m. ET, four major cryptocurrency transfers totaling $637.6 million took place. The largest were two Bitcoin transfers between unknown wallets, moving 3,543 BTC ($268.9M) and 2,022 BTC ($153.3M). Addi...

Market News
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App